(Q48347694)

10 February 2018

title

Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors. (English)

1 reference

10 February 2018

1 reference

1 reference

S Papapetropoulos

1

1 reference

10 February 2018

D C Mash

series ordinal

2

1 reference

10 February 2018

publication date

7 December 2006

1 reference

10 February 2018

Journal of Neural Transmission

published in

1 reference

10 February 2018

volume

114

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

341-345

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00702-006-0603-6

exact match

0 references

cites work

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-006-0603-6

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-006-0603-6

Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-006-0603-6

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

1 reference

12 December 2020

Disparities in the recording of Parkinson's disease on death certificates.

1 reference

12 December 2020

Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?

1 reference

12 December 2020

Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease

1 reference

12 December 2020

Risk factors for levodopa-induced dyskinesias in Parkinson's disease

1 reference

12 December 2020

Parkinsonism treated with levodopa: progression and mortality.

1 reference

12 December 2020

Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease

1 reference

12 December 2020

Motor fluctuations and dyskinesia in Parkinson's disease

1 reference

12 December 2020

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

12 December 2020

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1 reference

12 December 2020

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

1 reference

12 December 2020

Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations

1 reference

12 December 2020

Dopamine D-1 receptors in the parkinsonian brain

1 reference

12 December 2020

New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity

1 reference

12 December 2020

Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease

1 reference

12 December 2020

Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations.

1 reference

12 December 2020

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

1 reference

12 December 2020

10.1007/S00702-006-0603-6

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018